Mosby’s Nursing Consult Updated with New Content Areas and an Enhanced Mobile App

New content added for diseases and disorders, labs and diagnostics, and more

Philadelphia, PA, November 11, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the addition of new content types to Mosby's Nursing Consult. The latest edition will be available in early November, along with an enhanced mobile app for iPhone, iPad, iPod Touch and Android.

Mosby's Nursing Consult brings leading resources together in one integrated online platform to help nurses efficiently find answers to important clinical questions. Mosby's Nursing Consult is a trusted resource for clinical nurses, nurse administrators and nurse faculty.

New content areas and updates to Mosby's Nursing Consult include:

"In updating Mosby's Nursing Consult and its accompanying apps, we aimed to make available the most current and accurate drug information, patient handouts, and evidence-based nursing recommendations," said Cindy Tryniszewski, RN, MSN, Executive Director, Elsevier. "Nurses are focused on delivering quality patient care at all times, and these tools allow for their valuable time to be spent where needed."

Mosby's Nursing Consult puts trusted clinical information into nurses' hands and is the most trusted and comprehensive online resource for nurses, offering authoritative information to help provide better patient care. The Mosby's Nursing Consult App is available for free from the App Store for iPhone, iPad, and iPod touch or from Google Play for Android devices.

For additional information on Mosby's Nursing Consult, go to http://confidenceconnected.com or call +1 866 416 6697.


# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com